Department of Colorectal Surgery, Beaumont Hospital, Dublin 9, Ireland.
Department of Physiology and Medical Physicsand, RCSI Centre for Systems Medicine , Royal College of Surgeons in Ireland, Dublin 2, Ireland.
J Mol Med (Berl). 2023 Jul;101(7):829-841. doi: 10.1007/s00109-023-02324-5. Epub 2023 May 12.
There is currently an urgent need to identify factors predictive of immunogenicity in colorectal cancer (CRC). Mucinous CRC is a distinct histological subtype of CRC, associated with a poor response to chemotherapy. Recent evidence suggests the commensal facultative anaerobe Fusobacterium may be especially prevalent in mucinous CRC. The objectives of this study were to assess the association of Fusobacterium abundance with immune cell composition and prognosis in mucinous CRC. Our study included two independent colorectal cancer patient cohorts, The Cancer Genome Atlas (TCGA) cohort, and a cohort of rectal cancers from the Beaumont RCSI Cancer Centre (BRCC). Multiplexed immunofluorescence staining of a tumour microarray (TMA) from the BRCC cohort was undertaken using Cell DIVE technology. Our cohorts included 87 cases (13.3%) of mucinous and 565 cases (86.7%) of non-mucinous CRC. Mucinous CRC in the TCGA dataset was associated with an increased proportion of CD8 + lymphocytes (p = 0.018), regulatory T-cells (p = 0.001) and M2 macrophages (p = 0.001). In the BRCC cohort, mucinous RC was associated with enhanced CD8 + lymphocyte (p = 0.022), regulatory T-cell (p = 0.047), and B-cell (p = 0.025) counts. High Fusobacterium abundance was associated with an increased proportion of CD4 + lymphocytes (p = 0.031) and M1 macrophages (p = 0.006), whilst M2 macrophages (p = 0.043) were under-represented in this cohort. Patients with increased Fusobacterium relative abundance in our mucinous CRC TCGA cohort tended to have better clinical outcomes (DSS: likelihood ratio p = 0.04, logrank p = 0.052). Fusobacterium abundance may be associated with improved outcomes in mucinous CRC, possibly due to a modulatory effect on the host immune response. KEY MESSAGES: • Increased Fusobacterium relative abundance was not found to be associated with microsatellite instability in mucinous CRC. • Increased Fusobacterium relative abundance was associated with an M2/M1 macrophage switch, which is especially significant in mucinous CRC, where M2 macrophages are overexpressed. • Increased Fusobacterium relative abundance was associated with a significant improvement in disease specific survival in mucinous CRC. • Our findings were validated at a protein level within our own in house mucinous and non-mucinous rectal cancer cohorts.
目前迫切需要确定预测结直肠癌(CRC)免疫原性的因素。黏液性 CRC 是 CRC 的一种独特组织学亚型,与化疗反应差有关。最近的证据表明,兼性厌氧菌梭杆菌可能在黏液性 CRC 中特别普遍。本研究的目的是评估 Fusobacterium 丰度与黏液性 CRC 中免疫细胞组成和预后的关系。我们的研究包括两个独立的结直肠癌患者队列,即癌症基因组图谱(TCGA)队列和 Beaumont RCSI 癌症中心(BRCC)的直肠癌症队列。使用 Cell DIVE 技术对 BRCC 队列的肿瘤微阵列(TMA)进行了多重免疫荧光染色。我们的队列包括 87 例(13.3%)黏液性和 565 例(86.7%)非黏液性 CRC。TCGA 数据集中的黏液性 CRC 与 CD8+淋巴细胞比例增加相关(p=0.018),调节性 T 细胞(p=0.001)和 M2 巨噬细胞(p=0.001)。在 BRCC 队列中,黏液性 RC 与增强的 CD8+淋巴细胞计数(p=0.022)、调节性 T 细胞计数(p=0.047)和 B 细胞计数(p=0.025)相关。Fusobacterium 丰度高与 CD4+淋巴细胞比例增加相关(p=0.031)和 M1 巨噬细胞(p=0.006),而在该队列中 M2 巨噬细胞(p=0.043)的比例较低。在我们的 TCGA 黏液性 CRC 队列中,Fusobacterium 相对丰度增加的患者倾向于具有更好的临床结局(DSS:似然比 p=0.04,对数秩 p=0.052)。Fusobacterium 丰度可能与黏液性 CRC 的改善结局相关,可能是由于对宿主免疫反应的调节作用。关键信息:
在黏液性 CRC 中,增加的 Fusobacterium 相对丰度与微卫星不稳定性无关。
Fusobacterium 相对丰度的增加与 M2/M1 巨噬细胞转换相关,在黏液性 CRC 中尤其显著,其中 M2 巨噬细胞过度表达。
Fusobacterium 相对丰度的增加与黏液性 CRC 患者的疾病特异性生存显著改善相关。
我们的发现通过在我们自己的黏液性和非黏液性直肠癌症队列中的蛋白质水平得到了验证。